Jason Franklyn

Jason Franklyn's work experience spans across various industries and roles. Jason began their career as a Business Analyst at McKinsey & Company in 2004 and later transitioned to a role as an Associate at Polaris Venture Partners in 2006. In 2011, they returned to McKinsey & Company as a Senior Associate and subsequently served as an Engagement Manager until 2013.

Following their time at McKinsey, Franklyn joined Gilead Sciences in 2013 as a Product Manager in HIV Marketing, specializing in direct-to-patient and direct-to-consumer strategies. Jason was later promoted to Senior Product Manager in HCV Marketing and then Associate Director in HIV Sales.

In 2018, Franklyn joined Vir Biotechnology as the Director of Corporate Strategy, where they played a crucial role in shaping the company's strategic direction. Jason later assumed the position of Head of Strategy & Chief of Staff for the CEO in January 2020, demonstrating their ability to provide high-level strategic guidance to senior executives.

Overall, Franklyn's work experience exhibits a strong background in strategy, management, and marketing roles within the biotechnology and pharmaceutical industries.

Jason Franklyn attended Harrison College, where they obtained a High School degree with a focus on A Levels in Physics, Chemistry, Mathematics, and Further Mathematics. After that, they pursued a Bachelor's Degree in Chemical Engineering Systems with an individualized major at the University of Pennsylvania. Additionally, they obtained a Bachelor's Degree in Finance and Management from The Wharton School, which is also part of the University of Pennsylvania. Jason then went on to complete a Master's Degree in Biotechnology at the University of Pennsylvania. Lastly, they enrolled in the Stanford University Graduate School of Business to pursue a Master of Business Administration (M.B.A.) degree.